semaglutide hepatic impairment dosing versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Pharmacokinetics and tolerability of semaglutide

In our latest case study, we take a deep dive into the Reference Listed Drug Lupron Depot, showing how advanced polymer profiling ensures reproducibility, regulatory alignment, andmost importantlypatient safety in longacting injectables

Vegetarians and vegans often face challenges in obtaining sufficient B12 from their diet, so supplementation becomes necessary

Beyond glucose regulation, GIP agonists have been shown to modulate lipid metabolism, improve dyslipidemia, and reduce atherogenesis in low-density lipoprotein (LDL) receptor knockout mice 28

Hyponatraemia (low sodium levels) is a recognised risk with SSRIs including sertraline, particularly in older adults or those taking diuretics

The DELIVER trial randomized 6,263 patients with symptomatic HF, 74% of whom had NYHA class II symptoms, either with HF with moderately reduced ejection fraction (HFmrEF